GABLES CAPITAL MANAGEMENT INC. - INMED PHARMACEUTICALS INC ownership

INMED PHARMACEUTICALS INC's ticker is and the CUSIP is 457637601. A total of 15 filers reported holding INMED PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GABLES CAPITAL MANAGEMENT INC. ownership history of INMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10.0%10.0%0.00%
Q1 2023$1
-50.0%
10.0%0.00%
Q4 2022$210.0%0.00%
Q3 2022$010.00%
Other shareholders
INMED PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TD Waterhouse Canada Inc. 85$1250.00%
ROYAL BANK OF CANADA 11$00.00%
Advisory Services Network, LLC 6$60.00%
TCI Wealth Advisors, Inc. 5$60.00%
UBS Group AG 2,622$2,8320.00%
AllSquare Wealth Management LLC 21$230.00%
OSAIC HOLDINGS, INC. 41$430.00%
BANK OF AMERICA CORP /DE/ 1,822$1,9680.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
TORONTO DOMINION BANK 2$00.00%
View complete list of INMED PHARMACEUTICALS INC shareholders